關于我們 About
公司簡介
當前位置: 首頁 > 關于我們 > 公司簡介

image.png

上海博志研新藥物技術有限公司(簡稱“博志研新”)作為一家以改良型新藥、創新藥、高端制劑為核心的藥物研發和生產服務(CRO/CDMO)企業,致力于打造國際化,前沿化的醫藥研發和創新平臺。不僅在腫瘤、心血管、免疫、神經和精神等領域具有豐富的開發經驗,在高端制劑技術(口服緩控釋、口服固體增溶、長效注射液、液體與半固體等)方向上也具有豐富的專業經驗和創新技術優勢。

Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) was established in Shanghai Zhangjiang Pharma Valley in 2012. Having two internal R&D centers settled in Shanghai and Nanjing, and a subsidiary clinical company in Chengdu, Bocimed now established an efficient R&D team with about 200 staffs and possesses specialized R&D equipments worth more 40 million RMB. Our comprehensive R&D platform mainly focuses upon small molecule innovative drugs, modified innovative drugs, highly difficult pharmaceutical preparations, DMF&MAH and clinical research, committing to provide global pharmaceutical companies with extremely competitive drug and create international and frontier pharmaceutical R&D and innovative platform.


公司擁有100多項藥物開發技術,產品聚焦在腫瘤、心血管、免疫、神經和精神等多個治療領域。公司擁有完善的內部知識產權保障制度,現有已授權的發明專利16項,在審批中的發明專利47項。

Bocimed has more than 100 product development technologies, focusing on various therapeutic areas including oncology, cardiovascular science, immunology, neurological and mental health. With well-established internal intellectual property system,we have 16 authorized and 47 pending approval patents up to now.


COPYRIGHT 2015 上海博志研新藥物技術有限公司 滬ICP備13030567號-1 本公司保留一切版權 | 條款及細 上海浦東新區松濤路647弄1號樓

滬公網安備 31011502005223號